[go: up one dir, main page]

NO20091625L - Polymorf B pa N-(2-fluoro-5-[3-(tiopen-2-karbonyl)-pyrazolo[1,5-A]pyrimidin-7-yl]-fenyl)-N-metylacetamid - Google Patents

Polymorf B pa N-(2-fluoro-5-[3-(tiopen-2-karbonyl)-pyrazolo[1,5-A]pyrimidin-7-yl]-fenyl)-N-metylacetamid

Info

Publication number
NO20091625L
NO20091625L NO20091625A NO20091625A NO20091625L NO 20091625 L NO20091625 L NO 20091625L NO 20091625 A NO20091625 A NO 20091625A NO 20091625 A NO20091625 A NO 20091625A NO 20091625 L NO20091625 L NO 20091625L
Authority
NO
Norway
Prior art keywords
polymorph
pyrazolo
pyrimidin
fluoro
carbonyl
Prior art date
Application number
NO20091625A
Other languages
English (en)
Other versions
NO342008B1 (no
Inventor
Antonio Guglietta
Luis Anglada
Albert Palomer
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37789824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091625(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20091625L publication Critical patent/NO20091625L/no
Publication of NO342008B1 publication Critical patent/NO342008B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives en ny polymorf av N-{2-f[uor-5-[3-(tiofen-2-karbonyl)-pyrazolo[l,5-a]pyrimidin-7-yl-fenyl}-N-metyl-acetarnid. Videre beskrives det fremgangsmåter for fremstilling av polymorfen, dens anvendelse som et medikament, dens bruk ved fremstilling av et medikament, og farmasøytiske preparater inneholdende den nye polymorf.
NO20091625A 2006-10-11 2009-04-23 Polymorf B av polymorf B av N-{2-fluor-5-[3-(tiofen-2-karbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-fenyl)-N-metyl-acetamid NO342008B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85074306P 2006-10-11 2006-10-11
EP06122138A EP1918290A1 (en) 2006-10-11 2006-10-11 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
PCT/EP2007/060797 WO2008043800A1 (en) 2006-10-11 2007-10-10 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide

Publications (2)

Publication Number Publication Date
NO20091625L true NO20091625L (no) 2009-05-07
NO342008B1 NO342008B1 (no) 2018-03-12

Family

ID=37789824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091625A NO342008B1 (no) 2006-10-11 2009-04-23 Polymorf B av polymorf B av N-{2-fluor-5-[3-(tiofen-2-karbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-fenyl)-N-metyl-acetamid

Country Status (21)

Country Link
US (2) US8039476B2 (no)
EP (2) EP1918290A1 (no)
JP (1) JP5171831B2 (no)
KR (1) KR101418624B1 (no)
CN (1) CN101622257B (no)
AR (1) AR063231A1 (no)
AU (1) AU2007306319B2 (no)
BR (1) BRPI0717833A2 (no)
CA (1) CA2666653C (no)
CL (1) CL2007002928A1 (no)
DK (1) DK2081935T3 (no)
ES (1) ES2637137T3 (no)
MX (1) MX2009003571A (no)
NO (1) NO342008B1 (no)
PL (1) PL2081935T3 (no)
PT (1) PT2081935T (no)
RU (1) RU2413729C2 (no)
SI (1) SI2081935T1 (no)
TW (1) TWI391392B (no)
UY (1) UY30637A1 (no)
WO (1) WO2008043800A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1921079A1 (en) * 2006-11-08 2008-05-14 Ferrer Internacional, S.A. Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP2261999B1 (en) * 2008-03-31 2019-03-27 Kyocera Corporation Solar cell element and solar cell module
IT1391113B1 (it) * 2008-09-30 2011-11-18 Dipharma Francis Srl Procedimento per la preparazione di azelnidipina cristallina

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US399621A (en) * 1889-03-12 Canning-house truck
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
EP1214075B1 (en) * 1999-09-02 2004-06-16 Neurocrine Biosciences, Inc. POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO
CA2493359C (en) * 2002-08-26 2009-10-27 Neurocrine Biosciences, Inc. Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US7304069B2 (en) * 2004-10-18 2007-12-04 Neurocrine Biosciences, Inc. Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Also Published As

Publication number Publication date
BRPI0717833A2 (pt) 2014-06-10
JP2010505914A (ja) 2010-02-25
RU2009117716A (ru) 2010-11-20
PL2081935T3 (pl) 2018-04-30
US20110224234A1 (en) 2011-09-15
SI2081935T1 (sl) 2017-12-29
UY30637A1 (es) 2008-05-02
EP1918290A1 (en) 2008-05-07
US8039476B2 (en) 2011-10-18
CA2666653A1 (en) 2008-04-17
CA2666653C (en) 2014-12-30
DK2081935T3 (en) 2017-09-04
WO2008043800A1 (en) 2008-04-17
EP2081935A1 (en) 2009-07-29
PT2081935T (pt) 2017-08-29
CL2007002928A1 (es) 2008-05-09
EP2081935B1 (en) 2017-05-24
MX2009003571A (es) 2009-04-14
NO342008B1 (no) 2018-03-12
AU2007306319B2 (en) 2012-12-06
AR063231A1 (es) 2009-01-14
CN101622257A (zh) 2010-01-06
JP5171831B2 (ja) 2013-03-27
TW200827360A (en) 2008-07-01
ES2637137T3 (es) 2017-10-11
RU2413729C2 (ru) 2011-03-10
US20100087451A1 (en) 2010-04-08
KR101418624B1 (ko) 2014-07-15
AU2007306319A1 (en) 2008-04-17
CN101622257B (zh) 2013-03-27
US8273753B2 (en) 2012-09-25
KR20090077796A (ko) 2009-07-15
TWI391392B (zh) 2013-04-01

Similar Documents

Publication Publication Date Title
BRPI0923728A2 (pt) "método de preparação de compostos de di-hidroindeno amida, suas composições farmacêuticas contendo esses compostos e uso como inibidor de proteína quinase".
TW200745121A (en) Chemical compound
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
MX2010006436A (es) Derivados peptidos mimeticos de eritropoyetina y sus sales farmaceuticas, su preparacion y usos.
BRPI0408990A (pt) derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase
NO20070162L (no) Krystallinske former av (-)-(1R,2R)-3-(3-dimetylamino- 1-etyl-2-metylpropyl)-fenol-hydroklorid
WO2007092620A3 (en) Stable formulations, and methods of their preparation and use
EA200901138A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
MY152283A (en) Polo-like kinase inhibitirs
NO20080186L (no) Heterosykliske aspartylproteaseinhibitorer, fremstilling og anvendelse derav
BR122013028012B8 (pt) composto de ciclopentano de pirimidila hidroxilado e metoxilado, sua composição farmacêutica e seu método de preparação
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
BRPI0406762A (pt) Derivados de n-(1-benzil-2-oxo-2-(1-piperazinil)etil)-1-piperidincarb oxamida e compostos relacionados como antagonistas de cgrp, para tratamento de dores de cabeça
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
WO2007050587A3 (en) Therapeutic compositions and methods
WO2010011811A3 (en) 3-(phenoxyphenylmethyl)pyrrolidine compounds
WO2008074833A3 (en) Compounds
TW200942529A (en) Pyrrolidinyl derivatives and uses thereof
MY142474A (en) 1h-quinazoline-2,4-diones
NO20091625L (no) Polymorf B pa N-(2-fluoro-5-[3-(tiopen-2-karbonyl)-pyrazolo[1,5-A]pyrimidin-7-yl]-fenyl)-N-metylacetamid
NO20084177L (no) Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler
EA200600833A1 (ru) Тиазолидиноны, их получение и применение как фармацевтических агентов
NO20091334L (no) Fremgangsmate for syntese av klopidogrel og nye former for farmasoytisk akseptable salter derav
ATE401332T1 (de) Neue polymorphe von olanzapin-hydrochlorid

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees